Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,168
+$467 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#611
of 640 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $551,277 across 11 Biotechnology names. JAZZ ranks #4 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
110,500 | $530,400 | |
| 2 | BNTX |
BioNTech SE
|
80 | $7,444 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
134 | $7,308 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
9 | $2,168 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,107 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
15 | $585 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2 | $13 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,168 | 9 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,701 | 9 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $1,530 | 9 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,186 | 9 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,379 | 13 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $2,607 | 21 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,586 | 21 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,339 | 21 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,684 | 72 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $9,754 | 81 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,583 | 21 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $9,190 | 71 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $8,801 | 71 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,389 | 71 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $7,009 | 44 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $6,397 | 48 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $9,048 | 58 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,094 | 52 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,624 | 52 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $5,208 | 40 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $7,105 | 40 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $6,739 | 41 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $6,932 | 42 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $5,988 | 42 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $4,303 | 39 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $3,989 | 40 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||